Skip to main content

Advertisement

SpringerLink
Log in

A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bhagavathi S, Borromeo V, Desai H, Crisan D (2008) Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia. Ann Clin Lab Sci 38(4):405–409

    PubMed  Google Scholar 

  2. Nagao T, Takahashi N, Kameoka Y, Noguchi S, Shinohara Y, Ohyagi H, Kume M, Sawada K (2013) Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia. Intern Med 52(22):2567–2571

    Article  PubMed  Google Scholar 

  3. Serpa M, Bendit I, Seguro F et al (2010) Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia. Acta Haematol 124:105–109

    Article  PubMed  Google Scholar 

  4. Gargallo P, Cacchione R, Chena C et al (2005) Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events. Cancer Genet Cytogenet 161:74–77

    Article  CAS  PubMed  Google Scholar 

  5. Salim R, Wang L, Lin K, Clark RE (2002) Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukaemia. Leuk Lymph 43:2225–2227

    Article  CAS  Google Scholar 

  6. Chang H, Sutherland R, Nayar R, Li D, Kamel-Reid S, Mile MA et al (2004) Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting. Cancer Genet Cytogenet 152:146–148

    Article  CAS  PubMed  Google Scholar 

  7. Kumar N, Ahluwalia J, Malhotra P, Sachdeva MS (2013) Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia-accelerated phase: a rare case with review of the literature. Indian J Pathol Microbiol 56:303–305

    Article  PubMed  Google Scholar 

  8. Bartik MM, Welker D, Kay NE (1998) Impairments in immune function in B cell chronic lymphocytic leukemia. Semin Oncol 25:27–33

    CAS  PubMed  Google Scholar 

  9. Hisada M, Biggar RJ, Greene MH, Fraumeni JF, Travis LB (2001) Solid tumors after chronic lymphocytic leukemia. Blood 98:1979–1981

    Article  CAS  PubMed  Google Scholar 

  10. Jin HH, Won HJ, Myong SC, Lee M, Soon CW (2003) Acute lymphoblastic leukemia without Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome. Am J Hematol 74:218–220

    Article  Google Scholar 

  11. Zhang X, Ji L, Liu S, Wang J (2003) Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph positive chronic myelocytic leukemia. Leuk Res 27:367–369

    Article  PubMed  Google Scholar 

  12. Verma D, Kantarjian H, Strom SS, Rios MB, Jabbour E, Quintas-Cardama A et al (2011) Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies. Blood 118:4353–4358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Crescenzi B, Sacchi S, Marasca R et al (2002) Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia. Leukemia 16:955–956

    Article  CAS  PubMed  Google Scholar 

  14. Amrein PC (2011) The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms. Leuk Lymph 52:754–763

    Article  CAS  Google Scholar 

  15. Allen JC, Talab F, Zuzel M, Lin K, Slupsky JR (2011) c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells. Blood 117:2414–2422

    Article  CAS  PubMed  Google Scholar 

  16. Contri A, Brunati AM, Trentin L et al (2005) Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 115:369–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Amrein PC, Attar EC, Takvorian T et al (2011) Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. Clin Cancer Res 17:2977–2986

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Braziel RM, Launder TM, Druker BJ, Olson SB, Magenis RE, Mauro MJ, Sawyers SL, Paquette RL, O’Dwyer ME (2002) Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months’ experience. Blood 100(2):435–441

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Hematology, Clinical Centre of Vojvodina, Hajduk Veljkova 1-8, Novi Sad, 21000, Serbia

    Marina Dokic, Ivana Urosevic, Ivanka Savic, Borivoj Sekulic, Aleksandar Savic, Ivana Milosevic & Nebojsa Rajic

  2. Medical Faculty, University of Novi Sad, Novi Sad, Serbia

    Marina Dokic, Ivana Urosevic, Aleksandar Savic & Ivana Milosevic

Authors
  1. Marina Dokic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ivana Urosevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivanka Savic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Borivoj Sekulic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aleksandar Savic
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ivana Milosevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nebojsa Rajic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina Dokic.

Ethics declarations

Conflict of interest

Marina Dokic is member of Serbian Medical Association. Ivana Urosevic has received a speaker honorarium from Novartis. She is member of American Society of Hematology, European Hematology Association and Serbian Medical Association. Ivanka Savic has received a speaker honorarium from Roche, Pfizer, MSD and Jansen. She is member of Serbian Lymphoma Group, Serbian Myeloma Group and Serbian Medical Association. Borivoj Sekulic is a member of Serbian Medical Association. Aleksandar Savic is a member of American Society of Hematology, European Hematology Association and Serbian Medical Association. Ivana Milosevic is a member of European Hematology Association and Serbian Medical Association. Nebojsa Rajic has received a speaker honorarium from Novonordisk and Pfizer. He is member of Serbian Medical Association.

Ethical Approval

We declare that all procedures performed in this article involving human participant were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Written consent was obtained from the patient for publication of this case report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dokic, M., Urosevic, I., Savic, I. et al. A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia. Indian J Hematol Blood Transfus 32 (Suppl 1), 156–158 (2016). https://doi.org/10.1007/s12288-016-0638-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0638-2

Keywords

Search

Navigation